Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 13/8/2019
SIETES contiene 92794 citas

 
 
 1 a 20 de 26 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Williams CL, Jones ME, Swerdlow AJ, Botting BJ, Davies MC, Jacobs I, Bunch KJ, Murphy MFG, Sutcliffe AG. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation. BMJ 2018;362:k2644. [Ref.ID 102818]
2. Cita con resumen
Anónimo. FDA announces list of off-patent drugs with no competition. DIA Daily 2017:1. [Ref.ID 101658]
3.Enlace a cita original Cita con resumen
Wang R, Kim BV, van Wely M, Johnson NP, Costello MF, Zhang H, Ng EHY, Legro RS, Bhattacharya S, Norman RJ, Mol BWJ. Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis. BMJ 2017;356:j138. [Ref.ID 101407]
4.
Anónimo. Drugs for ovulation induction. Med Lett Drugs Ther 2011;53:86-8. [Ref.ID 91381]
5.Tiene citas relacionadas
Jensen A, Sharif H, Frederiksen K, Kjaer SK. Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study. BMJ 2009;338:580-3. [Ref.ID 85412]
6.Tiene citas relacionadas
Webb PM. Fertility drugs and ovarian cancer. BMJ 2009;338:551-2. [Ref.ID 85409]
7.
Olive DL. Gonadotropin-releasing hormone agonists for endometriosis. N Engl J Med 2008;359:1136-42. [Ref.ID 83930]
8. Cita con resumen
Sjöqvist F, Garle M, Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet 2008;371:1872-82. [Ref.ID 83085]
9. Cita con resumen
Dudzinski DM, Kesselheim AS. Scientific and legal viability of follow-on protein drugs. N Engl J Med 2008;358:843-9. [Ref.ID 82210]
10.
Al-Shawaf T, Zosmer A, Dirnfeld M, Grudzinskas JG. Safety of drugs used in assisted reproduction techniques. Drug Saf 2005;28:513-28. [Ref.ID 74169]
11. Cita con resumen
Anónimo. Managing anovulatory infertility. Drug Ther Bull 2004;42:28-32. [Ref.ID 69772]
13.Tiene citas relacionadas Cita con resumen
Wald NJ, Huttly WJ, Hackshaw AK. Antenatal screening for Down's syndrome with the quadruple test. Lancet 2003;361:835-6. [Ref.ID 65294]
14.Tiene citas relacionadas Cita con resumen
Benn P. Improved antenatal screening for Down's syndrome. Lancet 2003;361:794-5. [Ref.ID 65288]
15. Cita con resumen
Slattery MM, Morrison J J. Preterm delivery. Lancet 2002;360:1489-97. [Ref.ID 63997]
16. Cita con resumen
Lipscomb GH, Stovall TG, Ling FW. Nonsurgical treatment of ectopic pregnancy. N Engl J Med 2000;343:1325-9. [Ref.ID 53519]
17.
Gottlieb S. In vitro fertilisation is preferable to fertility drugs. BMJ 2000;321:134. [Ref.ID 51805]
18.Tiene citas relacionadas
Bhattacharya S, Templeton A. In treating fertility, are multiple pregnancies unavoidable?. N Engl J Med 2000;343:58-60. [Ref.ID 51723]
19.Tiene citas relacionadas Cita con resumen
Gleicher N, Oleske DM, Tur-Kaspa I, Vidali A, Karande V. Reducing the risk of high-order multiple pregnancy after ovarian stimulation with gonadotropins. N Engl J Med 2000;343:2-7. [Ref.ID 51719]
20. Cita con resumen
Seleccionar todas
 
 1 a 20 de 26 siguiente >>